ACS To open Key Positions To Competition In Massive “Reorganization for the ‘90’s
In Brief: CTEP Files IND For Antineoplaston, Mayo, MSK, Plan Trials; Researcher Escapes Bosnia
New ACS Structure Proposed, approved
Seffrin; First Year ACS Shows “Simple Problems Aren’t”
Diet Supplements Should Be Held To Scientific Standards, Broder Tells House
NCI Awards Regional CIS Contracts
FDA Encourages Study Of Gender Differences


Trending Stories
- Brawley: ACS prostate cancer screening guideline should say no to “mass screening”
- NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk - ACS strengthens recommendation for prostate cancer screening
Many will hear the endorsement and ignore the limitations - Kay “Taddy” Dickersin, NBCC co-founder, dies at 74
- CMS rule cuts overall oncology payments by estimated 2%
Final rule slashes 340B, moves toward site-neutrality - In the 90s, Barry Kramer persuaded NCI to get out of the business of screening guidelines
At the time, USPSTF was better equipped to do the job. Is it still?









